Mexiletine Hydrochloride Capsules USP
Company:  Danbury Pharmacal, Inc.
Application No.: ANDA 74-865
Approval Date:  4/13/98

• Approval Letter and Final Printed Labeling (1.2 MB)

• Bioequivalence Review(s) (1.4 MB)

• Administrative Documents and Correspondence (904 KB)

PDF requires the free Adobe Acrobat Reader

Date created: June 230, 2005

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research